The Institute of Pharmaceutical Innovation

Thursday 23rd March, 2006 Successful £4M AIM floatation for Bradford Bioscience Incubator client

SYNTOPIX GROUP PLC

FIRST DAY OF DEALINGS ON THE AIM MARKET OF
THE LONDON STOCK EXCHANGE

Syntopix Group plc, (AIM: SYN) a drug discovery and development company focused on dermatological diseases, announces its flotation on the AIM market of the London Stock Exchange today.

Highlights of the Placing:

• £4.0 million (£3.3 million net of expenses) has been raised for Syntopix via a placing at 177 pence per share
• On admission the market capitalisation of Syntopix at the placing price will be £10.1 million
• The proceeds of the placing will be used to finance the Company’s drug development programmes in dermatology

  KBC Peel Hunt Ltd is the Company’s Nominated Adviser and Broker

  Further Details

  For further details follow the link to the London Stock Exchange press release or the Syntopix web site.